| Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2 KM Parmar, HB Larman, G Dai, Y Zhang, ET Wang, SN Moorthy, JR Kratz, ... The Journal of clinical investigation 116 (1), 49-58, 2006 | 820 | 2006 |
| Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity E Shrock, E Fujimura, T Kula, RT Timms, IH Lee, Y Leng, ML Robinson, ... Science 370 (6520), eabd4250, 2020 | 586 | 2020 |
| Comprehensive serological profiling of human populations using a synthetic human virome GJ Xu, T Kula, Q Xu, MZ Li, SD Vernon, T Ndung’u, K Ruxrungtham, ... Science 348 (6239), aaa0698, 2015 | 447 | 2015 |
| Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens MJ Mina, T Kula, Y Leng, M Li, RD De Vries, M Knip, H Siljander, ... Science 366 (6465), 599-606, 2019 | 384 | 2019 |
| Hypophysitis secondary to cytotoxic T-lymphocyte–associated protein 4 blockade: insights into pathogenesis from an autopsy series P Caturegli, G Di Dalmazi, M Lombardi, F Grosso, HB Larman, T Larman, ... The American journal of pathology 186 (12), 3225-3235, 2016 | 351 | 2016 |
| Autoantigen discovery with a synthetic human peptidome HB Larman, Z Zhao, U Laserson, MZ Li, A Ciccia, MAM Gakidis, ... Nature biotechnology 29 (6), 535-541, 2011 | 339 | 2011 |
| Statins exert endothelial atheroprotective effects via the KLF2 transcription factor KM Parmar, V Nambudiri, G Dai, HB Larman, MA Gimbrone, ... Journal of Biological Chemistry 280 (29), 26714-26719, 2005 | 303 | 2005 |
| Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositis H Benjamin Larman, M Salajegheh, R Nazareno, T Lam, J Sauld, H Steen, ... Annals of neurology 73 (3), 408-418, 2013 | 293 | 2013 |
| COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva N Pisanic, PR Randad, K Kruczynski, YC Manabe, DL Thomas, A Pekosz, ... Journal of clinical microbiology 59 (1), 10.1128/jcm. 02204-20, 2020 | 240 | 2020 |
| Key transcriptional regulators of the vasoprotective effects of shear stress RA Boon, AJG Horrevoets Hämostaseologie 29 (01), 39-43, 2009 | 236 | 2009 |
| Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells G Villarreal Jr, Y Zhang, HB Larman, J Gracia-Sancho, A Koo, ... Biochemical and biophysical research communications 391 (1), 984-989, 2010 | 193 | 2010 |
| DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires JW Sidhom, HB Larman, DM Pardoll, AS Baras Nature communications 12 (1), 1605, 2021 | 151 | 2021 |
| Flow activation of AMP-activated protein kinase in vascular endothelium leads to Kruppel-like factor 2 expression A Young, W Wu, W Sun, HB Larman, N Wang, YS Li, JY Shyy, S Chien, ... Arteriosclerosis, thrombosis, and vascular biology 29 (11), 1902-1908, 2009 | 146 | 2009 |
| Directed cell migration via chemoattractants released from degradable microspheres X Zhao, S Jain, HB Larman, S Gonzalez, DJ Irvine Biomaterials 26 (24), 5048-5063, 2005 | 127 | 2005 |
| PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes D Mohan, DL Wansley, BM Sie, MS Noon, AN Baer, U Laserson, ... Nature protocols 13 (9), 1958-1978, 2018 | 124 | 2018 |
| PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis HB Larman, U Laserson, L Querol, K Verhaeghen, NL Solimini, GJ Xu, ... Journal of autoimmunity 43, 1-9, 2013 | 113 | 2013 |
| Protein interaction discovery using parallel analysis of translated ORFs (PLATO) J Zhu, HB Larman, G Gao, R Somwar, Z Zhang, U Laserson, A Ciccia, ... Nature biotechnology 31 (4), 331-334, 2013 | 66 | 2013 |
| Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality WR Morgenlander, SN Henson, DR Monaco, A Chen, K Littlefield, ... The Journal of clinical investigation 131 (7), 2021 | 63 | 2021 |
| Markers of polyfunctional SARS-CoV-2 antibodies in convalescent plasma H Natarajan, AR Crowley, SE Butler, S Xu, JA Weiner, EM Bloch, ... MBio 12 (2), 10.1128/mbio. 00765-21, 2021 | 58 | 2021 |
| Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10 KAK Finton, K Larimore, HB Larman, D Friend, C Correnti, PB Rupert, ... PLoS pathogens 9 (9), e1003639, 2013 | 57 | 2013 |
